Imperial College Reports Dual-Target CAR-iNKT Platform for Multiple Myeloma

Institution: Imperial College London · Event Type: Peer-Reviewed Preclinical Publication · Technology: CAR-iNKT Cell Therapy + iNKT Engager · Targets: BCMA / FCRL5 · Indication: Multiple Myeloma · Publication Date: August 14, 2026 Summary Imperial College London investigators reported a peer-reviewed preclinical strategy that combines…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

Astellas / AviadoBio – Gene Therapy Program Sustained via Nonprofit Funding
Samsung Biologics Moves Into Peptide Manufacturing
Boulevard Bio Launches with $65 Million
GSK – $1B SiranBio Oligo Deal